PH25044A - N9-cyclpentyl-substituted adenine derivatives and a method of use thereof - Google Patents

N9-cyclpentyl-substituted adenine derivatives and a method of use thereof

Info

Publication number
PH25044A
PH25044A PH36065A PH36065A PH25044A PH 25044 A PH25044 A PH 25044A PH 36065 A PH36065 A PH 36065A PH 36065 A PH36065 A PH 36065A PH 25044 A PH25044 A PH 25044A
Authority
PH
Philippines
Prior art keywords
cyclpentyl
adenine derivatives
substituted adenine
substituted
derivatives
Prior art date
Application number
PH36065A
Inventor
Jen Chen
Alan J Hutchison
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of PH25044A publication Critical patent/PH25044A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PH36065A 1986-11-14 1987-11-13 N9-cyclpentyl-substituted adenine derivatives and a method of use thereof PH25044A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93132786A 1986-11-14 1986-11-14

Publications (1)

Publication Number Publication Date
PH25044A true PH25044A (en) 1991-01-28

Family

ID=25460605

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36065A PH25044A (en) 1986-11-14 1987-11-13 N9-cyclpentyl-substituted adenine derivatives and a method of use thereof

Country Status (15)

Country Link
EP (1) EP0267878A1 (en)
JP (1) JPS63135384A (en)
KR (1) KR880006241A (en)
AU (1) AU608258B2 (en)
CA (1) CA1288431C (en)
DD (1) DD273833A5 (en)
DK (1) DK596087A (en)
FI (1) FI874982A7 (en)
HU (1) HU198489B (en)
IL (1) IL84414A0 (en)
NO (1) NO166184C (en)
NZ (1) NZ222527A (en)
PH (1) PH25044A (en)
PT (1) PT86120B (en)
ZA (1) ZA878527B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164556B (en) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US5015739A (en) * 1988-04-22 1991-05-14 Schering Corporation Processes for preparation of cyclopentyl purine derivatives
GB8813148D0 (en) * 1988-06-03 1988-07-06 Glaxo Group Ltd Chemical compounds
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
HU204843B (en) * 1988-09-27 1992-02-28 Merrell Dow Pharma Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8926417D0 (en) * 1989-11-22 1990-01-10 Wellcome Found Heterocyclic compounds
US5514688A (en) * 1990-09-14 1996-05-07 Merrell Dow Pharmaceuticals Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5470857A (en) * 1990-09-14 1995-11-28 Marion Merrell Dow Inc. Carbocyclic nucleoside analogs useful as immunosuppressants
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
US5817661A (en) 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817660A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5723466A (en) * 1991-12-06 1998-03-03 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
FR2685918B1 (en) * 1992-01-08 1995-06-23 Union Pharma Scient Appl NOVEL ADENOSINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5840923A (en) * 1992-04-21 1998-11-24 Chiroscience Limited Chiral cyclopentene derivatives and their preparation
AU3961493A (en) * 1992-04-21 1993-11-18 Chiroscience Limited Chiral cyclopentene derivatives and their preparation
IT1254915B (en) * 1992-04-24 1995-10-11 Gloria Cristalli ADENOSINE DERIVATIVES FOR ACTIVITY A2 AGONIST
EP0577558A2 (en) * 1992-07-01 1994-01-05 Ciba-Geigy Ag Carbocyclic nucleosides having bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
WO1996019478A1 (en) * 1994-12-19 1996-06-27 Novartis Ag 6'-substituted carbocyclic nucleosides
WO2000063703A1 (en) 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
AU3851601A (en) * 2000-02-18 2001-08-27 Southern Res Inst Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-9h- purin-6-amine
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
GT200500281A (en) 2004-10-22 2006-04-24 Novartis Ag ORGANIC COMPOUNDS.
GB0500785D0 (en) 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607950D0 (en) 2006-04-21 2006-05-31 Novartis Ag Organic compounds
PE20080361A1 (en) 2006-04-21 2008-06-03 Novartis Ag PURINE-DERIVED COMPOUNDS AS ADENOSINE A2A RECEPTOR ACTIVATORS
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
AU2011329854B2 (en) * 2010-11-16 2017-03-30 University Of Southern California CBP/catenin antagonists for enhancing asymmetric division of somatic stem cells
CN105061431B (en) * 2015-07-28 2017-03-29 山东百诺医药股份有限公司 6‑N‑（2‑（Methyl mercapto）Ethyl）‑2‑（（3,3,3 trifluoro propyls）It is thio）9H purine and its preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610985A1 (en) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab (1)-Aminopurinyl-(1)-deoxyribofuranuronic acid medicaments - with circulatory, cardiac and metabolic activity
US4345984A (en) * 1981-03-02 1982-08-24 The Procter & Gamble Company Novel prostaglandin analogues and process for making same
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines

Also Published As

Publication number Publication date
DK596087D0 (en) 1987-11-13
FI874982A0 (en) 1987-11-11
NO874749L (en) 1988-05-16
NZ222527A (en) 1990-08-28
PT86120B (en) 1990-08-31
KR880006241A (en) 1988-07-22
HUT45057A (en) 1988-05-30
NO874749D0 (en) 1987-11-13
HU198489B (en) 1989-10-30
DD273833A5 (en) 1989-11-29
FI874982A7 (en) 1988-05-15
CA1288431C (en) 1991-09-03
JPS63135384A (en) 1988-06-07
NO166184B (en) 1991-03-04
EP0267878A1 (en) 1988-05-18
DK596087A (en) 1988-05-15
ZA878527B (en) 1988-05-16
IL84414A0 (en) 1988-04-29
AU8119387A (en) 1988-05-19
NO166184C (en) 1991-06-12
PT86120A (en) 1987-12-01
AU608258B2 (en) 1991-03-28

Similar Documents

Publication Publication Date Title
PH25044A (en) N9-cyclpentyl-substituted adenine derivatives and a method of use thereof
PL278545A1 (en) Method of obtaining novel derivatives of cyclobutylpurine and cyclobutylpyrimidine
EP0273355A3 (en) A rear axlecase and methods of manufacturing thereof
YU236989A (en) Derivatives of 2-iminobenzothiazoline and process for obtaining thereof
PL266148A1 (en) A herbicide and a method of new 3-benzoyl-4-ketolactams derivatives production
YU72387A (en) Process for obtaining derivatives of benzimidazole-2-sulphonamide and imidazopyridin-2-sulphonamide
PH23367A (en) Purine derivatives,composition and method of use thereof
PL266144A1 (en) Weedicidal specific and the method of manufacturing of new derivatives of 3-amino-2-benzoylcyclohexene-2-ane-1
PL266143A1 (en) Weedicidal specific and the method of manufacturing of new derivatives of 2-benzoylcyclohexene-2-ane-1
IL83798A (en) 13-deoxy-23-oxo(keto)and 23-imino derivatives of 13-deoxy c-076-aglycone compounds and their pesticidal use
PH24460A (en) 2,3,4,10-tetrahydropyrimido(1,2-a)indoles and a method of use thereof
PH22427A (en) Eburnamenine derivatives and method of use thereof
GB2204313B (en) Novel bisbenzotrifluoride derivatives and method of preparing same
GB2197182B (en) Sleeve arrangement and method of manufacture thereof
PL257438A1 (en) Method of obtaining a podofilotoxin and its derivatives
PL274231A1 (en) Method of obtaining purine derivatives
PL265398A1 (en) A fungicide and a method of new thiocyanopyrimidine derivatives production
BG41900A1 (en) Derivatives of alkylthienyl- aminoalcohols and method for their preparation
BG42259A1 (en) Malonoylic derivatives of 3- methyl- 1- phenylpyrazolon- 5 and method for their preparation
CS56288A1 (en) Derivatives of adenine
BG44121A1 (en) Azomethinic derivatives of 5- nitrofurfurol and method for its preparation
PL260837A1 (en) A method of obtaining 0-formylcephamandol and its salts
BG40731A1 (en) Derivatives of 3- cynamoyl- 2h- 1- benzopyran- 2- on and method for their preparing
PL261055A2 (en) Method of obtaining alpha-chloroacetanilide derivatives
BG41051A1 (en) Triazoderivatives of resorzine and method for its manufacture and use